Clinical trial
Efficacy of Erzhi Tiangui Granules on Live Birth Rate in Advanced-age Women With Poor Ovarian Response Undergoing in Vitro Fertilization: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
NCT05698550 is registered in ClinicalTrials.gov with Shandong University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Erzhi Tiangui Granules on Live Birth Rate in Advanced-age Women With Poor Ovarian Response Undergoing in Vitro Fertilization: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
- Lead sponsor
- Shandong University of Traditional Chinese Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2023
- Completion date
- December 31, 2025
- Enrollment
- 480 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.